by Jason Rutten | Aug 26, 2019 | news
Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of significant and clinically-meaningful outcomes from a prospective, open-label, single-arm, multi-center study...
by Jason Rutten | Jun 25, 2019 | news
Relievant Medsystems, a privately-held medical device company focused on transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of the Level I INTRACEPT Study results in The Spine Journal. The INTRACEPT Study is a Level I,...
by Jason Rutten | Apr 23, 2019 | news
Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART trial in the International Journal of Spine Surgery. A total of...
by Jason Rutten | Feb 25, 2019 | news
Results from the pre-specified interim analysis of the landmark INTRACEPT randomized controlled trial were presented for first time on February 20, 2019 at the American Society of Spine Radiology (ASSR) meeting in Miami, Fla. The study demonstrated statistically and...
by Jason Rutten | Feb 13, 2019 | news
Relievant Medsystems, a privately-held medical device company, developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that a pre-specified interim analysis of the Level I INTRACEPT Randomized Controlled Trial (RCT) found a highly...